Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy sold 933 shares of the company’s stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $107.29, for a total value of $100,101.57. Following the completion of the sale, the executive vice president now directly owns 27,533 shares of the company’s stock, valued at approximately $2,954,015.57. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Shares of Varian Medical Systems, Inc. (NYSE:VAR) traded up 0.14% during trading on Thursday, hitting $107.83. The company had a trading volume of 518,881 shares. The company has a market capitalization of $9.90 billion, a P/E ratio of 35.49 and a beta of 0.58. Varian Medical Systems, Inc. has a 52 week low of $75.20 and a 52 week high of $107.84. The stock’s 50-day moving average price is $101.14 and its 200 day moving average price is $97.06.

Varian Medical Systems (NYSE:VAR) last announced its earnings results on Wednesday, July 26th. The medical equipment provider reported $1.04 EPS for the quarter, topping the Zacks’ consensus estimate of $0.95 by $0.09. The firm had revenue of $662.40 million during the quarter, compared to analysts’ expectations of $663.86 million. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The company’s quarterly revenue was up 3.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.00 EPS. On average, equities research analysts forecast that Varian Medical Systems, Inc. will post $3.93 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This piece of content was first reported by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark law. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/09/14/insider-selling-varian-medical-systems-inc-var-evp-sells-933-shares-of-stock.html.

Several institutional investors have recently made changes to their positions in VAR. BlackRock Inc. boosted its holdings in shares of Varian Medical Systems by 3,169.5% in the 1st quarter. BlackRock Inc. now owns 7,899,768 shares of the medical equipment provider’s stock worth $719,907,000 after purchasing an additional 7,658,148 shares during the period. Janus Henderson Group PLC boosted its holdings in shares of Varian Medical Systems by 1,545.7% in the 2nd quarter. Janus Henderson Group PLC now owns 3,754,727 shares of the medical equipment provider’s stock worth $387,450,000 after purchasing an additional 3,526,571 shares during the period. Koch Industries Inc. boosted its holdings in shares of Varian Medical Systems by 57,988.4% in the 2nd quarter. Koch Industries Inc. now owns 1,327,901 shares of the medical equipment provider’s stock worth $1,315,000 after purchasing an additional 1,325,615 shares during the period. FMR LLC boosted its holdings in shares of Varian Medical Systems by 324.5% in the 1st quarter. FMR LLC now owns 1,006,924 shares of the medical equipment provider’s stock worth $91,760,000 after purchasing an additional 769,718 shares during the period. Finally, Arrowstreet Capital Limited Partnership bought a new stake in shares of Varian Medical Systems during the 2nd quarter worth approximately $77,323,000. Hedge funds and other institutional investors own 99.64% of the company’s stock.

Several brokerages have weighed in on VAR. BidaskClub upgraded Varian Medical Systems from a “buy” rating to a “strong-buy” rating in a research report on Thursday, June 22nd. Aegis reiterated a “hold” rating and issued a $91.00 price objective on shares of Varian Medical Systems in a research report on Wednesday, May 17th. BTIG Research downgraded Varian Medical Systems from a “buy” rating to a “neutral” rating in a research report on Thursday, September 7th. They noted that the move was a valuation call. Robert W. Baird reiterated a “neutral” rating and issued a $99.00 price objective (up previously from $89.00) on shares of Varian Medical Systems in a research report on Friday, July 14th. Finally, Zacks Investment Research downgraded Varian Medical Systems from a “buy” rating to a “hold” rating in a research report on Thursday, July 13th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and two have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $97.39.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.